Mesh-like scaffold is disordered in Alzheimer's-affected cells
News Feb 06, 2016
Skeleton that protects brain cells' control center is found to be damaged -
Brain cell death in Alzheimer's disease is linked to disruption of a skeleton that surrounds the nucleus of the cells, a researcher in the School of Medicine at The University of Texas (UT) Health Science Center at San Antonio said.
The finding is expected to open new avenues of study of how to prevent the earliest biological events that result in Alzheimer's.
The nucleus is the control center of cells. A mesh-like scaffold called the lamin nucleoskeleton surrounds this control center but is disordered in Alzheimer's, said Bess Frost, PhD, assistant professor of cellular and structural biology at the UT Health Science Center at San Antonio. Dr Frost was trained at Harvard Medical School and in November started her new laboratory at the UT Health Science Center's Barshop Institute for Longevity and Aging Studies.
Confirmed in human cells
Dr Frost and two co-authors showed—for the first time—that lamin dysfunction can cause the death of neurons. The team made this finding in a fruit fly disease model initially and confirmed it in postmortem brain tissue of people who had Alzheimer's disease, whose families donated their brains to research.
"Human brain donation is a very critical part of this work," Dr Frost said. "It was important to show that what we found in the fly is really relevant to human disease."
Dr Frost and her colleagues used a technique called super-resolution microscopy to analyze the fruit fly and human specimens. They found peculiar features that looked like tunnels in the lamin of Alzheimer's-affected specimens.
A cell nucleus from a normal, healthy brain is shown at left. The lamin nucleoskeleton forms the perimeter around the nucleus. By contrast, tunnel-like anomalies are evident in the nucleus of the Alzheimer's disease-affected cell shown at right. Credit: Lab of Bess Frost, UT Health Science Center San Antonio
Seems to be Alzheimer's-specific
The team also studied a fruit fly model of Huntington's disease and did not find any problems with the lamin. "So, at least compared to one other neurodegenerative disease, lamin dysfunction seems to be specific to Alzheimer's disease," Dr Frost said.
The findings, made while Dr Frost was at Harvard and Brigham and Women's Hospital, are in in the journal Current Biology.
Dr Frost encourages people to consider brain donation, whether or not they have a neurodegenerative disease. Comparing healthy, normal brain tissue to diseased brain tissue is a very useful tool for neuroscientists, she said.
New Alzheimer's institute
A state-of-the-art tissue biorepository will be part of the Institute for Alzheimer and Neurodegenerative Diseases announced by the Health Science Center in September 2015. The biobank will be linked to a database containing the health history of each donor.
Dr Frost said she is very excited that the institute is being launched and plans to be involved once it is operational. Dr Frost is establishing her laboratory with support from The University of Texas System Rising STARS Award. STARS stands for Science and Technology Acquisition and Retention.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Frost B, Bardai FH, Feany MB. Lamin Dysfunction Mediates Neurodegeneration in Tauopathies. Current Biology, Published January 11 2016. doi: 10.1016/j.cub.2015.11.039
Researchers Find a Way to Separate Side Effects of Opioid Drugs Reducing RiskNews
Scientists have discovered a way to separate these two effects -- pain relief and breathing, opening a window of opportunity to make effective pain medications without the risk of respiratory failure.READ MORE
Biological Mechanism of a Leading Cause of Childhood Blindness RevealedNews
Scientists have revealed the pathology of cells and structures stricken by optic nerve hypoplasia, a leading cause of childhood blindness in developed nations.READ MORE
Machine Learning: Helping Determine How a Drug Affects the BrainNews
Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new UCL study published today in Brain.READ MORE